Intuitive Surgical, Inc. (NASDAQ:ISRG) Position Increased by Paloma Partners Management Co

Paloma Partners Management Co increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2,305.5% in the third quarter, Holdings Channel.com reports. The institutional investor owned 4,811 shares of the medical equipment provider’s stock after acquiring an additional 4,611 shares during the period. Paloma Partners Management Co’s holdings in Intuitive Surgical were worth $2,364,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also recently added to or reduced their stakes in the company. Ridgewood Investments LLC bought a new stake in Intuitive Surgical in the 2nd quarter valued at about $26,000. Godsey & Gibb Inc. boosted its position in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after buying an additional 35 shares during the period. LGT Financial Advisors LLC grew its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical in the 3rd quarter valued at approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in Intuitive Surgical during the 2nd quarter valued at $37,000. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $542.00 on Monday. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $552.00. The firm has a market capitalization of $193.05 billion, a price-to-earnings ratio of 87.14, a P/E/G ratio of 5.33 and a beta of 1.39. The company has a 50 day moving average price of $510.03 and a 200 day moving average price of $469.49.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Jamie Samath sold 108 shares of the firm’s stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This represents a 26.54 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 50,459 shares of company stock worth $26,080,251. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms have recently issued reports on ISRG. Raymond James increased their price target on Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a research note on Monday, October 14th. Truist Financial boosted their price target on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research report on Monday, October 14th. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a report on Friday, October 11th. BTIG Research boosted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Finally, Wells Fargo & Company increased their price target on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $526.06.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.